Dopamine Genotypes, Experimentally-induced Craving, & Cessation in Female Smokers

多巴胺基因型,实验诱发的渴望,

基本信息

  • 批准号:
    7207894
  • 负责人:
  • 金额:
    $ 16.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-01 至 2009-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Project Summary: The objective of this exploratory/developmental R21 application is to characterize and better understand the effects of genetic polymorphisms in the dopamine system on stress- & smoking cue- induced cigarette cravings and smoking cessation among women who smoke. Grounded in a diverse literature, the proposed multidisciplinary prospective study of women interested in making an untreated, 'cold turkey' smoking cessation attempt will provide a naturalistic look at potential effects of dopamine-related genotypes and stress- & cue-induced cravings elicited under laboratory conditions, on abstinence. To that end, 250 women will be genotyped for dopamine-related polymorphisms, participate in laboratory stress and cue-exposure tasks the day before their target quit date, and will be assessed for abstinence at 8 time points during a 6-month follow-up interval. By closely examining relations between experimentally-induced craving reactions and cessation, the study will attempt to better characterize mechanisms underlying the effects of dopamine genotypes. This first study will lay the groundwork for larger-scale investigations aimed at determining the beneficial effects of tailored treatments (e.g., cue-exposure, stress management, nicotine replacement) in the context of genetic (e.g., dopamine polymorphisms) and psychobiological (e.g., cue- and stress-induced craving reactions) characteristics in samples of both men and women, with an eye toward yielding a better undestanding of the unique challenges experienced by women trying to quit smoking. Relevance: Smoking is the single most preventable cause of morbidity and mortality in the United States. Indeed, smoking has been implicated in at least 30 percent of all cancer deaths in the U.S. and an estimated three million deaths per year worldwide. In spite of the clear negative consequences of smoking, a significant subset of the population continues to smoke. Moreover, although most smokers express a strong interest in quitting, few are successful at maintaining abstinence, a problem that is even more pronounced among women. Persistent smoking behavior (i.e., failure or difficulty in remaining abstinent) thus continues to be a major public health problem. Understanding the genetic and psychobiological determinants of smoking cessation success is a critical first step in developing novel approaches to promote cessation, so necessary to reduce the alarming rates of cancer and other smoking-related chronic diseases.
项目概述:这个探索性/发展性R21申请的目的是表征和更好地理解多巴胺系统遗传多态性对吸烟女性中压力和吸烟线索诱导的香烟渴望和戒烟的影响。在多种文献的基础上,对有兴趣进行未经治疗的“突然停止”戒烟尝试的女性进行多学科前瞻性研究,将提供一个自然的视角,研究多巴胺相关基因型和实验室条件下压力和线索诱导的渴望对戒烟的潜在影响。为此,将对250名妇女进行多巴胺相关多态性基因分型,在目标戒烟日期的前一天参加实验室压力和线索暴露任务,并在6个月的随访间隔中,在8个时间点评估戒烟情况。通过仔细研究实验诱导的渴望反应和戒烟之间的关系,该研究将试图更好地描述多巴胺基因型影响的机制。这第一项研究将为更大规模的调查奠定基础,旨在确定在男性和女性样本的遗传(例如,多巴胺多态性)和心理生物学(例如,线索和压力诱导的渴望反应)特征背景下定制治疗(例如,提示暴露,压力管理,尼古丁替代)的有益效果,以期更好地理解女性试图戒烟所经历的独特挑战。相关性:吸烟是美国发病率和死亡率的唯一最可预防的原因。事实上,美国至少有30%的癌症死亡与吸烟有关,全球每年约有300万人死于吸烟。尽管吸烟有明显的负面后果,但仍有相当一部分人继续吸烟。此外,尽管大多数吸烟者对戒烟表现出强烈的兴趣,但很少有人能成功地保持戒烟,这一问题在女性中更为明显。因此,持续吸烟行为(即未能或难以保持戒烟)仍然是一个主要的公共卫生问题。了解戒烟成功的遗传和心理生物学决定因素是开发促进戒烟的新方法的关键的第一步,因此有必要降低癌症和其他与吸烟有关的慢性疾病的惊人比率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joel Erblich其他文献

Joel Erblich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joel Erblich', 18)}}的其他基金

STANDOUT in Behavioral Cancer Prevention and Control Research: Summer Training Accelerating and Nurturing the Development of Outstanding Undergraduate Trainees
行为癌症防治研究脱颖而出:暑期培训加速培养优秀本科生
  • 批准号:
    10672273
  • 财政年份:
    2022
  • 资助金额:
    $ 16.95万
  • 项目类别:
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
1/2 TUFCCC/HC 区域综合癌症健康差异伙伴关系
  • 批准号:
    10251230
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
(2/2) TUFCCC/HC 区域综合癌症健康差异伙伴关系
  • 批准号:
    10524224
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:
Elucidating the Roles of Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease among Asian American Patients with Chronic Hepatitis B
阐明代谢综合征和非酒精性脂肪肝在亚裔美国慢性乙型肝炎患者中的作用
  • 批准号:
    10878354
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
1/2 TUFCCC/HC 区域综合癌症健康差异伙伴关系
  • 批准号:
    9789014
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
(2/2) TUFCCC/HC 区域综合癌症健康差异伙伴关系
  • 批准号:
    10018470
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
(2/2) TUFCCC/HC 区域综合癌症健康差异伙伴关系
  • 批准号:
    10411441
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:
1/2 TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
1/2 TUFCCC/HC 区域综合癌症健康差异伙伴关系
  • 批准号:
    10462703
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10707765
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:
(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership
(2/2) TUFCCC/HC 区域综合癌症健康差异伙伴关系
  • 批准号:
    10248416
  • 财政年份:
    2018
  • 资助金额:
    $ 16.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了